KENNETH MCCLAIN to Prospective Studies
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Prospective Studies.
Connection Strength
0.059
-
Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study. Blood Adv. 2020 08 11; 4(15):3754-3766.
Score: 0.019
-
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2017 05; 64(5).
Score: 0.015
-
Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol Oncol. 1994 Nov; 16(4):314-9.
Score: 0.013
-
Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. J Pediatr. 2008 Nov; 153(5):700-5, 705.e1-2.
Score: 0.008
-
Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med. 1997 Jan 30; 336(5):317-23.
Score: 0.004